Pure Global AI
ANVISA registration 10339840565Valid until Dec 15, 2035

ANTI-TSH RECEPTOR ANTIBODY (TRAb) - NEONATAL SCREENING

ANVISA Registration Number: 10339840565DIASORIN LTDADIASORIN ITALIA S.P.A.Risk Class III
Verified
Device names
Technical name
ANTI-TSH RECEPTOR ANTIBODY (TRAb) - NEONATAL SCREENING
View exact technical-name matches →
PT: ANTICORPO ANTI-RECEPTOR DE TSH (TRAb) - TRIAGEM NEONATAL
Commercial name
Família LIAISON® TSH-R Ab
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
10339840565
Process Number
25351177688202522
CNPJ
01896764000170
Company information
Registration Holder
DIASORIN LTDA
Manufacturer
DIASORIN ITALIA S.P.A.
Manufacturing Country
Italy
PT: ITÁLIA
Dates and status
Publication Date
Dec 15, 2025
Validity
15/12/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTI-TSH RECEPTOR ANTIBODY (TRAb) - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840565 and manufactured by DIASORIN ITALIA S.P.A.. The registration is held by DIASORIN LTDA with validity until Dec 15, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.